Search results
Results from the WOW.Com Content Network
Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company. 2009: Sanofi Pasteur acquires major stake in Hyderabad-based Shantha Biotechnics. [21] 2020: Sanofi Pasteur and GlaxoSmithKline have said they are starting clinical trials of their ...
Two class action lawsuits have been filed charging Sanofi Pasteur Inc. with violating U.S. antitrust laws, as a result of its bundling practices. [10] [11] The suits challenge Sanofi's alleged “anticompetitive scheme” [12] to maintain its monopoly in the U.S. meningitis vaccine market. [13] [14] These lawsuits have since been consolidated. [15]
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [ 4 ] [ 5 ] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.
Connaught was merged with Institut Mérieux in 1989, and in 1999 it was transformed into the Canadian component of "Pasteur Mérieux Connaught", owned by Rhône-Poulenc. A series of acquisitions since then have transferred ownership of what used to be the Connaught Laboratories to the global vaccine business of Sanofi.
The vaccine development branch of the institute was separated early on and is now part of Sanofi Pasteur. [ 1 ] , [ 2 ] , [ 3 ] The current name was changed in 2009 from Mérieux Alliance. [ 1 ] The holding is owned through the Mérieux Alliance company at 68% by Alain and Alexandre Mérieux and at 32% by the Christophe and Rodolphe Mérieux ...
Reported adverse effects were generally mild, with pain at the injection site being the most common adverse effect. [22] Some older, egg-based H5N1 vaccines for humans that have been licensed are: Sanofi Pasteur's vaccine approved by the United States in April 2007, [23] [24]
A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB. [2] [3] [4] TriHIBit and Tripedia were discontinued in 2011. [5]
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...